Literature DB >> 15854954

Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.

Shun-ichi Watanabe1, Hisao Asamura, Kenji Suzuki, Ryosuke Tsuchiya.   

Abstract

BACKGROUND: Clinical diagnosis of the nodal status is a significant factor in determining the treatment and predicting the prognosis in lung cancer patients. A patient with clinical N1 (cN1) disease is usually considered to be a candidate for surgical intervention in the present staging system in non-small cell lung cancer (NSCLC). However, cN1 disease is a subset for which the method of treatment and surgical results are variable, simply because both upstaging and downstaging can occur. We evaluated the surgical and pathologic results of cN1 NSCLC patients to reveal the problems in diagnosis and surgical management for this subset.
METHODS: From January 1998 to March 2003, 1,606 patients underwent thoracotomy for primary lung cancer at the National Cancer Center Hospital. Among them, the subjects for this study were 168 (10.5%) NSCLC patients who were clinically diagnosed as having N1 disease and underwent surgery without induction therapy.
RESULTS: The tumor cell types of these 168 cN1 NSCLC patients were adenocarcinoma in 73 (44%) and squamous cell carcinoma in 79 (47%). Pneumonectomy was performed in 26% (n = 43) patients, bilobectomy in 15% (n = 25), and exploratory thoracotomy in 11% (n = 19). Of 19 exploratory thoracotomy cases, 10 cases were due to pleural dissemination. The pathologic nodal status of the 135 patients who underwent pulmonary resection and mediastinal dissection was pN0, 19% (n = 25); pN1, 44% (n = 59); and pN2-3, 37% (n = 51). Of the 55 adenocarcinomas, 60% (n = 33) were revealed to be N2 disease on pathologic examination. There were no significant differences in the serum tumor markers between the pN1 and pN2 groups. Among the 25 patients who were downstaged postoperatively (cN1-pN0), 21 patients (84%) showed obstructive pneumonia in the lung.
CONCLUSIONS: In the staging process of cN1 disease, it will be helpful to perform mediastinoscopy and thoracoscopy to avoid unnecessary thoracotomy especially in adenocarcinoma, even though mediastinal nodes and pleural dissemination were negative on computed tomography investigation. Since extensive pulmonary resection (bilobectomy or pneumonectomy) was required in 41% of the patients, preoperative detailed cardiopulmonary function tests should be mandatory to reduce surgical morbidity and mortality. On the other hand, when pneumonia due to airway obstruction by the tumor exists, false-positive hilar nodes can be expected.

Entities:  

Mesh:

Year:  2005        PMID: 15854954     DOI: 10.1016/j.athoracsur.2004.11.025

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

1.  Early recurrence of completely resected N2-positive non-small-cell lung cancer.

Authors:  Takuma Tsukioka; Noritoshi Nishiyama; Takashi Iwata; Nobuhiro Izumi; Shinjiro Mizuguchi; Ryuhei Morita; Kiyotoshi Inoue; Shigefumi Suehiro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-03

2.  Histological type predicts mediastinal metastasis and surgical outcome in resected cN1 non-small cell lung cancer.

Authors:  Tetsuya Mizuno; Takaaki Arimura; Hiroaki Kuroda; Noriaki Sakakura; Yasushi Yatabe; Yukinori Sakao
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-06-28

3.  Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer.

Authors:  Masaya Tamura; Isao Matsumoto; Yusuke Tanaka; Daisuke Saito; Shuhei Yoshida; Munehisa Takata; Hirofumi Takemura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-09-18

4.  Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer.

Authors:  Paul J Speicher; Zachary W Fitch; Brian C Gulack; Chi-Fu J Yang; Betty C Tong; David H Harpole; Thomas A D'Amico; Mark F Berry; Matthew G Hartwig
Journal:  Ann Thorac Surg       Date:  2016-07-29       Impact factor: 4.330

5.  Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer.

Authors:  Takayuki Fukui; Katsuhiko Kato; Toshiki Okasaka; Koji Kawaguchi; Koichi Fukumoto; Shota Nakamura; Shuhei Hakiri; Naoki Ozeki; Kohei Yokoi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-09-02

6.  Surgical treatment of clinical N1 non-small cell lung cancer: ongoing controversy over diagnosis and prognosis.

Authors:  Kei Miyoshi; Takeshi Mimura; Koichiro Iwanaga; Shuji Adachi; Noriaki Tsubota; Morihito Okada
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

7.  Predicted extracapsular invasion of hilar lymph node metastasis by fusion positron emission tomography/computed tomography in patients with lung cancer.

Authors:  Takashi Makino; Yoshinobu Hata; Hajime Otsuka; Satoshi Koezuka; Kazutoshi Isobe; Nobumi Tochigi; Nobuyuki Shiraga; Kazutoshi Shibuya; Sakae Homma; Akira Iyoda
Journal:  Mol Clin Oncol       Date:  2015-07-01

8.  Exploratory thoracotomy and its influence on the survival of patients with lung cancer.

Authors:  Lucka Debevec; Janez Erzen; Andrej Debeljak; Anton Crnjac; Viljem Kovac
Journal:  Wien Klin Wochenschr       Date:  2006-08       Impact factor: 1.704

Review 9.  Lymph node dissection for lung cancer: past, present, and future.

Authors:  Shun-ichi Watanabe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-15

10.  Video-assisted radiofrequency ablation for pleural disseminated non-small cell lung cancer.

Authors:  Yaxing Shen; Ming Zhong; Wei Jiang; Hong Fan; Hao Wang; Qun Wang
Journal:  BMC Surg       Date:  2013-06-13       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.